Cargando…
Metabolic Profiling of CSF: Evidence That Early Intervention May Impact on Disease Progression and Outcome in Schizophrenia
BACKGROUND: The identification of schizophrenia biomarkers is a crucial step towards improving current diagnosis, developing new presymptomatic treatments, identifying high-risk individuals and disease subgroups, and assessing the efficacy of preventative interventions at a rate that is not currentl...
Autores principales: | Holmes, Elaine, Tsang, Tsz M, Huang, Jeffrey T.-J, Leweke, F. Markus, Koethe, Dagmar, Gerth, Christoph W, Nolden, Brit M, Gross, Sonja, Schreiber, Daniela, Nicholson, Jeremy K, Bahn, Sabine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1551919/ https://www.ncbi.nlm.nih.gov/pubmed/16933966 http://dx.doi.org/10.1371/journal.pmed.0030327 |
Ejemplares similares
-
CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis
por: Huang, Jeffrey T.-J., et al.
Publicado: (2007) -
Disease Biomarkers in Cerebrospinal Fluid of Patients with First-Onset Psychosis
por: Huang, Jeffrey T.-J, et al.
Publicado: (2006) -
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial
por: Leweke, F. Markus, et al.
Publicado: (2021) -
Profiling of CSF: Author's Reply
por: Bahn, Sabine, et al.
Publicado: (2006) -
Clinical bioinformatics for complex disorders: a schizophrenia case study
por: Schwarz, Emanuel, et al.
Publicado: (2009)